Lipid-lowering therapy: Do hospitals influence the prescribing behavior of general practitioners?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 40, Issue 7, 2002, Pages 317-321

  Schroder Bernhardi D ^a   Dietlein, G ^a  

^a IQVIA   (United States)

Author keywords

Hospital drug treatment; Lipid lowering therapy; Prescribing behavior of general practitioners

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL ESTERASE; ENZYME INHIBITOR; FIBRIC ACID DERIVATIVE;

ARTICLE; CASE STUDY; CONTROLLED STUDY; DATA BASE; DRUG INDICATION; GENERAL PRACTITIONER; GERMANY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PHYSICIAN; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; LONGITUDINAL STUDY; MEDICAL PRACTICE; PHYSICIAN ATTITUDE; PRESCRIPTION; CLINICAL PRACTICE; DRUG UTILIZATION; FACTUAL DATABASE; GENERAL HOSPITAL; HYPERCHOLESTEROLEMIA; MEDICAL RECORD; PRACTICE GUIDELINE;

ANTILIPEMIC AGENTS; DATABASES, FACTUAL; DRUG UTILIZATION; GERMANY; GUIDELINE ADHERENCE; HOSPITALS, GENERAL; HUMANS; HYPERCHOLESTEROLEMIA; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG;

EID: 0035991921     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP40317     Document Type: Article

References (24)

1. Factors influencing GPs decisions on the treatment of hypercholesterolemic patients
2. Use of the mediplus patient database in healthcare research
3. The risks of venous thromboembolitic disease among German women using oral contraceptives: A database study
4. Lipid-lowering interventions in managed care settings
5. Statins: Under-used by those who would benefit
6. Maximizing the cost-effectiveness of lipid-lowering therapy
7. Clinical context: Current concepts of coronary heart disease management
8. Economics of drug treatment: For which patients is it cost-effective to lower cholesterol?
9. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients
10. Migraine prescription density and recommendations
11. Changes in the utilization of lipid-lowering drugs over a 6-year period in a Danish population
12. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
13. Trends in long-term management of survivors of myocardial infarction by cardiologists in a government university-affiliated hospital
14. Pro and con: Low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management
15. Treatment behavior of doctor's regarding Helicobacter pylori infections
16. Postmarketing surveillance of adverse drug reactions: A correlational study approach using multiple data sources
17. Prescription drug use and costs among diabetic patients in primary healthcare practices in Germany
18. The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: Evidence from large-scale statin and fibrate trials
19. Influence of hospitals on the prescription behavior of doctors in office
20. Drug utilization research on the basis of a longitudinal patient database
21. Compliance with prescription recommendations by physicians in practices
22. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs
23. Prevention of coronary heart disease in clinical practice
24. The use of fibrates and of statins in preventing atherosclerosis in diabetes